These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12541213)

  • 21. Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age.
    Sundaram A; Alshaikh B; Dersch-Mills D; Dobry J; Akierman AR; Yusuf K
    Clin Ther; 2017 Jun; 39(6):1233-1241. PubMed ID: 28579209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended interval dosing of gentamicin in preterm infants.
    Mercado MC; Brodsky NL; McGuire MK; Hurt H
    Am J Perinatol; 2004 Feb; 21(2):73-7. PubMed ID: 15017470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum concentration of gentamicin in newborn infants].
    Töpke B; Buchenau W; Karstädt U; Linke M; Schlenstein S
    Kinderarztl Prax; 1990 Apr; 58(4):191-7. PubMed ID: 2366406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants.
    Ambalavanan N; Wu TJ; Tyson JE; Kennedy KA; Roane C; Carlo WA
    J Pediatr; 2003 Jun; 142(6):656-61. PubMed ID: 12838194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
    J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gentamicin dosing regimen for neonates: once daily].
    van Haelst IM; Hilarius DL; Hack WW
    Ned Tijdschr Geneeskd; 1998 Jun; 142(26):1521-2. PubMed ID: 9752075
    [No Abstract]   [Full Text] [Related]  

  • 29. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety.
    Juul SE; McPherson RJ; Bauer LA; Ledbetter KJ; Gleason CA; Mayock DE
    Pediatrics; 2008 Aug; 122(2):383-91. PubMed ID: 18676557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between the combination of azlocillin-gentamicin and ampicillin-gentamicin in the treatment of a nursery population.
    Fogel D; Farfel L; Miskin A; Mogilner BM
    Isr J Med Sci; 1983 Nov; 19(11):1009-15. PubMed ID: 6662683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
    Brown MS; Eichorst D; Lala-Black B; Gonzalez R
    Pediatrics; 2009 Oct; 124(4):e681-7. PubMed ID: 19786428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gentamicin dosage recommendations for neonates based on half-life predictions from birthweight.
    Charlton CK; Needelman H; Thomas RW; Kortas K
    Am J Perinatol; 1986 Jan; 3(1):28-32. PubMed ID: 3942611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
    Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
    Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tolerability of once-daily-dosing of intravenous gentamicin in preterm neonates born at 32-37 weeks of gestation].
    Miron D; Steinfeld M; Hasanein J; Felszer C; Reich D
    Harefuah; 2003 Jun; 142(6):413-5, 487. PubMed ID: 12858823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are perinatal risk factors helpful in predicting and optimizing treatment strategies for transient hypothyroxinemia in very-low-birth-weight infants?
    Kantor Herring MJ; Leef KH; Locke RG; Stefano JL; Bartoshesky L; Paul DA
    Am J Perinatol; 2003 Aug; 20(6):333-9. PubMed ID: 14528403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gentamicin administration in newborns: once daily].
    Kaspers GJ; Teunissen PC; Holl H
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):583-6. PubMed ID: 9623116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress markers and antioxidant status after oral iron supplementation to very low birth weight infants.
    Braekke K; Bechensteen AG; Halvorsen BL; Blomhoff R; Haaland K; Staff AC
    J Pediatr; 2007 Jul; 151(1):23-8. PubMed ID: 17586185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.